Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155

This study has been completed.
Information provided by (Responsible Party):
Astellas Pharma Inc Identifier:
First received: January 6, 2009
Last updated: August 20, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: August 20, 2015